Are full-body MRI scans actually worth it?
Companies like Prenuvo and Neko will scan you head to toe for a few thousand dollars. Here is what the evidence says about whole-body scans for healthy people.
By Yash Malviya
Published

The pitch is irresistible. For a couple of thousand dollars, no doctor's referral and no needle, a machine scans you head to toe and tells you whether anything sinister is hiding inside. Companies like Prenuvo and Neko Health, the body-scan startup backed by Spotify's founder, have turned that pitch into waitlists tens of thousands long. The promise is peace of mind, and the belief that catching something early always saves lives. The evidence tells a more complicated story.
Do doctors recommend full-body scans for healthy people?

Almost none do. The American College of Radiology and the US Preventive Services Task Force both advise against whole-body screening for people without symptoms. The reason is not cost or gatekeeping. It is that scanning a healthy body tends to find things, and most of those things do not matter.
What the scans actually find
The numbers are striking. Dr. Brian Dontchos, a radiologist at Fred Hutch, pointed to data in which 95 percent of asymptomatic people who had a whole-body MRI showed at least one abnormal finding, and 91 percent of those findings turned out to be irrelevant. Actual cancer appeared in 1 to 2 percent. A systematic review found a false-positive rate around 16 percent. In plain terms, for every real problem the scan catches, it raises a pile of false alarms.
Those false alarms are not harmless. An incidental finding, a spot on a kidney or a nodule on a lung, sets off more scans, specialist visits, anxiety and sometimes a biopsy that carries its own risk. In one large population study, 30 percent of people scanned received an incidental finding, and of the biopsies that followed, 62 percent found nothing malignant. Doctors call the deeper trap overdiagnosis: finding a "cancer" so slow-growing it would never have harmed you, then treating it anyway.
There is also what the scans quietly miss. Whole-body MRI is poor at catching early lung and colorectal cancer, two of the biggest killers, so a clean result can hand you false reassurance exactly where you need real vigilance. And the headline claim, that these scans save lives, has not been shown. As the surgical oncologist David Gorski notes, Prenuvo has "not published any studies finding that these scans catch diseases early and improve people's health." Without a proper trial, "caught it early" cannot be separated from lead-time bias, which is just knowing about a disease for longer without living any longer.
So should you ever get one?
If you have symptoms, a family history, or a specific risk, a targeted scan ordered by a doctor can be exactly right. The problem is the blanket sell to healthy people who feel fine, the same bundle now tucked inside six-figure longevity clubs.
So what earns its place? The unglamorous, proven screenings, done on schedule: colonoscopy, mammography, cervical screening, blood pressure, cholesterol and the standard blood work your doctor already knows to order. They are cheaper, backed by decades of trials, and aimed at the conditions that genuinely kill people. A good screening test, as Dr. Dontchos put it, should be inexpensive, accessible and low-harm. A luxury full-body scan is none of those things.
Peace of mind is a reasonable thing to want. Just know that the version sold in a scanner often delivers the opposite: a finding you did not need, a fear you cannot unsee, and a bill for both.
Read next
Do biological age tests actually work? and our full look at the longevity clubs charging up to $100,000 a year.
Sources
- Pricey whole-body MRIs don't add up, Fred Hutch
- ACR Statement on Screening Total Body MRI, American College of Radiology
- The return of marketing hype for whole body scans, now with AI, Science-Based Medicine
- Whole-body MRI screening: systematic review of false positives and cancer detection, PubMed
- Longevity clinics around the world are selling unproven treatments, MIT Technology Review